The Wendy's Company’s WEN focus on Breakfast daypart offerings, efforts to expand footprint across the Republic of Georgia, Uzbekistan and Kazakhstan, and menu innovation bode well. The company’s shares have gained 12.8% in the past six months, compared with the industry’s rally of 13.6%. The aforementioned factors are likely to drive the stock higher in the coming days.The Zacks Rank #2 (Buy) company has an impressive long-term earnings growth rate of 14%. In the past 60 days, earnings estimate 2021 and 2022 have witnessed upward revisions of 7.2% and 5%, respectively.Growth DriversWendy’s continues to focus on Breakfast daypart Offerings to drive incremental sales. Since its launch on Mar 2, 2020 across the United States, the model has contributed 6.2%, 6.4% and 6.3% to U.S. systemwide same-restaurant sales during fiscal second, third and fourth quarter of 2020, respectively. During the fiscal fourth quarter, breakfast made up for approximately 7% of sales. In first-quarter 2021, breakfast accounted for nearly 7% of sales. It contributed significantly to restaurant average unit volumes (or AUV). The company has been benefiting from its marketing efforts, high-quality offerings, repeat ordering and high customer satisfaction levels. Going forward, it remains bullish on this business model with plans to boost breakfast daypart sales by 30% in 2021. Image Source: Zacks Investment ResearchRecently, Wendy's announced three expansion agreements with the owners of Kusto Group and Global Investors Limited. This collaboration will help the company bolster its brand expansion in Central Asia within the next nine years. Wendy’s expects to bolster presence across the Republic of Georgia, Uzbekistan and Kazakhstan by 2030 through this partnership. The company anticipates boosting store count to 65 in the region.The company continues to impress investors with robust global same-restaurant sales growth. After posting global same-restaurant sales growth of 4.3% and 4.7% in third and fourth-quarter 2020, respectively, the company reported global restaurants comps sales improvement of 13%. Wendy's first-quarter 2021 global comps growth surpassed its own expectations. Comps in the United States witnessed an increase of 13.5% compared with flat in the year-ago quarter. The upside was driven by strength of rest-of-day business, breakfast, digital and stimulus payments. Internationally, the company’s same-restaurant sales grew 7.9% in first-quarter courtesy of robust performance of Canadian and Puerto Rico business.Margin, an important financial metric that gives an indication about the company’s health, has accelerated in first-quarter fiscal 2021. Company-operated restaurant margin was 17% in the reported quarter compared with 10.1% in the year-ago quarter. The increase can primarily be attributed to higher average check. However, this was partially offset by customer count declines due to the pandemic and rise in labor costs. In 2021, company-operated restaurant margin is expected in the range of 16% to 17% owing to increase in sales outlook and rise in average checks.Other Key PicksSome other top-ranked stocks, which warrant a look in the same space, include Bloomin' Brands, Inc. BLMN, Papa John's International, Inc. PZZA and Ruth's Hospitality Group, Inc. RUTH. All these stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Bloomin' Brands has reported better-than-expected earnings in each of the trailing four quarters, with average surprise being 85.2%.Papa John's International has an impressive long-term earnings growth rate of 15%.Ruth's Hospitality earnings in 2021 is likely to witness growth of 381.6% year over year. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ruths Hospitality Group, Inc. (RUTH): Free Stock Analysis Report The Wendys Company (WEN): Free Stock Analysis Report Papa Johns International, Inc. (PZZA): Free Stock Analysis Report Bloomin Brands, Inc. (BLMN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research